Foresite Capital Management III’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-62,245
| Closed | -$2.12M | – | 11 |
|
|
2020
Q1 | $2.12M | Buy |
+62,245
| New | +$2.12M | 3.37% | 8 |
|
|
2019
Q4 | – | Sell |
-53,345
| Closed | -$2.23M | – | 14 |
|
|
2019
Q3 | $2.23M | Sell |
53,345
-11,904
| -18% | -$497K | 0.85% | 14 |
|
|
2019
Q2 | $2.86M | Sell |
65,249
-11,130
| -15% | -$487K | 0.94% | 17 |
|
|
2019
Q1 | $3.93M | Sell |
76,379
-29,327
| -28% | -$1.51M | 1.02% | 17 |
|
|
2018
Q4 | $3.91M | Hold |
105,706
| – | – | 1.28% | 15 |
|
|
2018
Q3 | $3.97M | Hold |
105,706
| – | – | 0.88% | 20 |
|
|
2018
Q2 | $4.18M | Hold |
105,706
| – | – | 0.9% | 17 |
|
|
2018
Q1 | $2.72M | Hold |
105,706
| – | – | 0.59% | 18 |
|
|
2017
Q4 | $2.85M | Buy |
+105,706
| New | +$2.85M | 0.8% | 15 |
|
|
2017
Q3 | – | Sell |
-30,000
| Closed | -$750K | – | 30 |
|
|
2017
Q2 | $750K | Buy |
+30,000
| New | +$750K | 0.25% | 22 |
|